Pharmaceuticals,
Journal Year:
2023,
Volume and Issue:
16(10), P. 1384 - 1384
Published: Sept. 29, 2023
This
comprehensive
review
delves
into
the
rapidly
evolving
arena
of
cancer
vaccines.
Initially,
we
examine
intricate
constitution
tumor
microenvironment
(TME),
a
dynamic
factor
that
significantly
influences
heterogeneity.
Current
research
trends
focusing
on
harnessing
TME
for
effective
vaccine
treatments
are
also
discussed.
We
then
provide
detailed
overview
current
state
concerning
immunity
and
mechanisms
vaccines,
describing
complex
immunological
processes
involved.
Furthermore,
conduct
an
exhaustive
analysis
contemporary
landscape
with
particular
focus
peptide
DNA/RNA-based
viral-vector-based
dendritic-cell-based
whole-cell-based
analyze
summarize
these
categories
highlighting
their
individual
advantages,
limitations,
factors
influencing
effectiveness.
In
our
survey
each
category,
commonly
used
aiming
to
readers
more
understanding
research.
delve
innovative
strategy
combining
vaccines
other
therapies.
By
studying
effects
immune
checkpoint
inhibitors,
radiotherapy,
chemotherapy,
targeted
therapy,
oncolytic
virotherapy,
establish
this
approach
can
enhance
overall
treatment
efficacy
offset
limitations
single-treatment
approaches,
offering
patients
options.
Following
this,
undertake
meticulous
entire
process
personalized
elucidating
from
design,
through
production,
clinical
application,
thus
helping
gain
thorough
its
complexities.
conclusion,
exploration
in
aims
highlight
promising
potential
treatment.
As
field
continues
evolve,
it
undeniably
holds
immense
promise
improving
patient
outcomes.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(6), P. 1893 - 1893
Published: March 22, 2023
Cancer
has
been
the
first
killer
that
threatens
people’s
lives
and
health.
Despite
recent
improvements
in
cancer
treatment,
metastasis
continues
to
be
main
reason
for
death
from
cancer.
The
functions
of
microbiome
have
studied
recently,
it
is
proved
can
influence
tumor
metastasis,
as
well
positive
or
negative
responses
therapy.
Here,
we
summarize
mechanisms
microorganisms
affecting
which
include
epithelial-mesenchymal
transition
(EMT),
immunity,
fluid
shear
stress
(FSS),
matrix
metalloproteinases
(MMPs).
This
review
will
not
only
give
a
further
understanding
relationship
between
but
also
provide
new
perspective
microbiome’s
application
prevention,
early
detection,
treatment.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 16, 2024
The
extracellular
matrix
(ECM)
is
a
complex
three-dimensional
structure
composed
of
proteins,
glycans,
and
proteoglycans,
constituting
critical
component
the
tumor
microenvironment.
Complex
interactions
among
immune
cells,
matrix,
cells
promote
development
metastasis,
consequently
influencing
therapeutic
efficacy.
Hence,
elucidating
these
interaction
mechanisms
pivotal
for
precision
cancer
therapy.
T
lymphocytes
are
an
important
system,
exerting
direct
anti-tumor
effects
by
attacking
or
releasing
lymphokines
to
enhance
effects.
ECM
significantly
influences
function
infiltration
within
microenvironment,
thereby
impacting
behavior
biological
characteristics
cells.
involved
in
regulating
synthesis,
degradation,
remodeling
through
secretion
cytokines
enzymes.
As
result,
it
affects
proliferation
invasive
ability
as
well
efficacy
immunotherapy.
This
review
discusses
underlying
lymphocyte-ECM
microenvironment
their
potential
application
It
provides
novel
insights
innovative
strategies
drug.
Targets,
Journal Year:
2024,
Volume and Issue:
2(2), P. 104 - 125
Published: June 5, 2024
Fibrosarcoma
represents
a
significant
challenge
in
oncology,
characterized
by
high
invasiveness
and
poor
prognosis.
Gelatinases,
particularly
matrix
metalloproteinases
MMP-2
MMP-9,
play
pivotal
role
the
degradation
of
extracellular
matrix,
facilitating
tumor
invasion
metastasis.
Inhibiting
these
enzymes
has
emerged
as
promising
therapeutic
strategy.
This
review
evaluates
progress
development
potential
gelatinase
inhibitors
treatments
for
fibrosarcoma
over
last
decade,
highlighting
molecular
mechanisms
future
directions.
A
comprehensive
literature
was
conducted,
focusing
on
studies
published
from
2013
to
2023.
Research
articles
papers
relevant
inhibition
were
examined
assess
efficacy
inhibitors.
Gelatinase
have
shown
reduce
progression,
invasion,
metastasis
fibrosarcoma.
Clinical
trials,
although
limited,
indicated
that
can
be
effectively
integrated
into
existing
regimens,
offering
reduction
metastatic
spread
potentially
improving
patient
survival
rates.
Mechanistic
suggest
MMP-9
disrupts
critical
pathways
involved
growth
cell
invasion.
viable
approach
treatment.
Future
research
should
focus
developing
more
specific
inhibitors,
understanding
long-term
outcomes,
integrating
multimodal
treatment
strategies
enhance
efficacy.
Frontiers in Cell and Developmental Biology,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 13, 2025
The
primary
node
molecules
in
the
cell
signaling
network
cancer
tissues
are
maladjusted
and
mutated
comparison
to
normal
tissues,
which
promotes
occurrence
progression
of
cancer.
Pancreatic
(PC)
is
a
highly
fatal
with
increasing
incidence
low
five-year
survival
rates.
Currently,
there
several
therapies
that
target
networks
PC.
However,
PC
"cold
tumor"
unique
immunosuppressive
tumor
microenvironment
(poor
effector
T
infiltration,
antigen
specificity),
targeting
single
gene
or
pathway
basically
ineffective
clinical
practice.
Targeted
matrix
therapy,
targeted
metabolic
mutant
vaccines,
other
emerging
have
shown
great
therapeutic
potential,
but
results
been
disappointing.
Therefore,
we
summarize
identified
potential
drug-resistant
aimed
at
overcoming
barriers
existing
therapies.
Journal of Advanced Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
The
invasion
and
metastasis
of
pancreatic
cancer
(PC)
are
key
factors
contributing
to
disease
progression
poor
prognosis.
This
process
is
primarily
driven
by
EMT,
which
has
been
the
focus
recent
studies
highlighting
role
long
non-coding
RNAs
(lncRNAs)
as
crucial
regulators
EMT.
However,
mechanisms
lncRNAs
influence
invasive
multifaceted,
extending
beyond
EMT
regulation
alone.
review
aims
characterize
affecting
in
cancer.
We
summarize
regulatory
roles
across
multiple
molecular
pathways
highlight
their
translational
potential,
considering
implications
for
clinical
applications
diagnostics
therapeutics.
focuses
on
three
principal
scientific
themes.
First,
we
orchestrate
various
signaling
pathways,
such
TGF-β/Smad,
Wnt/β-catenin,
Notch,
regulate
changes
associated
with
thereby
enhancing
cellular
motility
invasivenes.
Second,
effects
autophagy
ferroptosis
discuss
exosomal
tumor
microenvironment
behavior
neighboring
cells
promote
cell
invasion.
Third,
emphasize
RNA
modifications
(such
m6A
m5C
methylation)
stabilizing
capacity
mediate
PC.
Lastly,
potential
these
findings,
emphasizing
inherent
challenges
using
biomarkers
therapeutic
targets,
while
proposing
prospective
research
strategies.
Biology,
Journal Year:
2022,
Volume and Issue:
11(2), P. 339 - 339
Published: Feb. 21, 2022
Tumor
metastasis
is
a
major
cause
of
death
in
cancer
patients.
It
involves
not
only
the
intrinsic
alterations
within
tumor
cells,
but
also
crosstalk
between
these
cells
and
components
microenvironment
(TME).
Tumorigenesis
complex
dynamic
process,
involving
following
three
main
stages:
initiation,
progression,
metastasis.
The
transition
stages
depends
on
changes
extracellular
matrix
(ECM),
which
stromal
reside.
This
matrix,
under
effect
growth
factors,
cytokines,
adipokines,
can
be
morphologically
altered,
degraded,
or
reorganized.
Many
cancers
evolve
to
form
an
immunosuppressive
TME
locally
create
pre-metastatic
niche
other
tissue
sites.
niches
include
myofibroblasts,
immuno-inflammatory
(macrophages),
adipocytes,
blood,
lymphatic
vascular
networks.
Several
studies
have
highlighted
adipocyte-macrophage
interaction
as
key
driver
progression
dissemination.
two
classes
macrophages
are
distinguished:
M1
(pro-inflammatory/anti-tumor)
M2
(anti-inflammatory/pro-tumor).
These
exhibit
distinct
microenvironment-dependent
phenotypes
that
promote
inhibit
On
hand,
obesity
patients
has
been
linked
poor
prognosis.
In
this
regard,
tumor-associated
adipocytes
modulate
through
secretion
inflammatory
mediators,
recruit
(TAM).
Hereby,
review
describes
cellular
molecular
mechanisms
link
inflammation,
obesity,
cancer.
provides
comprehensive
overview
ECM
they
control
invasion.
addition,
it
addresses
anchoring
recruitment
for
M1,
M2,
TAM
macrophages,
specifically
highlighting
their
origin,
classification,
polarization,
regulatory
networks,
well
roles
regulation
angiogenesis,
invasion,
metastasis,
immunosuppression,
role
process.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(10), P. 8824 - 8824
Published: May 16, 2023
Luteolin
(3',4',5,7-tetrahydroxyflavone),
a
member
of
the
flavonoid
family
derived
from
plants
and
fruits,
shows
wide
range
biomedical
applications.
In
fact,
due
to
its
anti-inflammatory,
antioxidant
immunomodulatory
activities,
Asian
medicine
has
been
using
luteolin
for
centuries
treat
several
human
diseases,
including
arthritis,
rheumatism,
hypertension,
neurodegenerative
disorders
various
infections.
Of
note,
displays
many
anti-cancer/anti-metastatic
properties.
Thus,
purpose
this
review
consists
in
highlighting
relevant
mechanisms
by
which
inhibits
tumor
progression
metastasis,
i.e.,
affecting
epithelial-mesenchymal
transition
(EMT),
repressing
angiogenesis
lysis
extracellular
matrix
(ECM),
as
well
inducing
apoptosis.